Rochester, MN, United States of America

Phillip G Rowse

This inventor holds 2 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2019-2020.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Phillip G Rowse in Medical Devices

Introduction

Phillip G Rowse is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of medical devices, particularly in improving procedures related to thoracostomy. With a total of 2 patents, his work focuses on enhancing patient care and safety.

Latest Patents

Phillip's latest patents include innovative devices such as CO2-sensing chest tube and needle thoracostomy devices. These inventions provide systems and methods that can improve the efficacy of tube and needle thoracostomy. For instance, his patents offer devices and methods for confirming the proper placement of a chest tube or needle within the pleural space to relieve a pneumothorax or tension pneumothorax. This advancement is crucial for ensuring effective treatment in emergency medical situations.

Career Highlights

Phillip G Rowse is associated with the Mayo Foundation for Medical Education and Research, where he continues to develop groundbreaking medical technologies. His work is instrumental in advancing the field of thoracic medicine and improving patient outcomes.

Collaborations

Phillip has collaborated with notable colleagues such as Johnathon M Aho and Raaj K Ruparel. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Phillip G Rowse's contributions to medical device innovation demonstrate his commitment to enhancing healthcare practices. His patents reflect a dedication to improving patient safety and treatment efficacy in critical medical procedures.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…